[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Febrile Neutropenia Market - Global Outlook and Forecast 2021-2027

April 2021 | 93 pages | ID: FC91C70F6345EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Febrile Neutropenia in Global, including the following market information:

Global Febrile Neutropenia Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Febrile Neutropenia market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Febrile Neutropenia companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Febrile Neutropenia Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Febrile Neutropenia Market Segment Percentages, By Type, 2020 (%)
  • Pegfilgrastim
  • Vancomycin Hydrochloride
  • Filgrastim Biosimilars
  • Pegfilgrastim Biosimilars
  • Others
China Febrile Neutropenia Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Febrile Neutropenia Market Segment Percentages, By Application, 2020 (%)
  • Hospitals
  • Clinics
  • Others
Global Febrile Neutropenia Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Febrile Neutropenia Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Febrile Neutropenia Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Febrile Neutropenia Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Xenetic Biosciences, Inc. (XBIO)
  • Richter Gedeon Nyrt.
  • Amgen Inc.
  • Hospira, Inc.
  • Eli Lilly and Company
  • USV Private Limited
  • Aequus BioPharma, Inc.
  • Taiho Pharmaceutical Co., Ltd.
  • BeyondSpring Inc.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Febrile Neutropenia Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Febrile Neutropenia Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL FEBRILE NEUTROPENIA OVERALL MARKET SIZE

2.1 Global Febrile Neutropenia Market Size: 2021 VS 2027
2.2 Global Febrile Neutropenia Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Febrile Neutropenia Players in Global Market
3.2 Top Global Febrile Neutropenia Companies Ranked by Revenue
3.3 Global Febrile Neutropenia Revenue by Companies
3.4 Top 3 and Top 5 Febrile Neutropenia Companies in Global Market, by Revenue in 2020
3.5 Global Companies Febrile Neutropenia Product Type
3.6 Tier 1, Tier 2 and Tier 3 Febrile Neutropenia Players in Global Market
  3.6.1 List of Global Tier 1 Febrile Neutropenia Companies
  3.6.2 List of Global Tier 2 and Tier 3 Febrile Neutropenia Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Febrile Neutropenia Market Size Markets, 2021 & 2027
  4.1.2 Pegfilgrastim
  4.1.3 Vancomycin Hydrochloride
  4.1.4 Filgrastim Biosimilars
  4.1.5 Pegfilgrastim Biosimilars
  4.1.6 Others
4.2 By Type - Global Febrile Neutropenia Revenue & Forecasts
  4.2.1 By Type - Global Febrile Neutropenia Revenue, 2016-2021
  4.2.2 By Type - Global Febrile Neutropenia Revenue, 2022-2027
  4.2.3 By Type - Global Febrile Neutropenia Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Febrile Neutropenia Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Febrile Neutropenia Revenue & Forecasts
  5.2.1 By Application - Global Febrile Neutropenia Revenue, 2016-2021
  5.2.2 By Application - Global Febrile Neutropenia Revenue, 2022-2027
  5.2.3 By Application - Global Febrile Neutropenia Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Febrile Neutropenia Market Size, 2021 & 2027
6.2 By Region - Global Febrile Neutropenia Revenue & Forecasts
  6.2.1 By Region - Global Febrile Neutropenia Revenue, 2016-2021
  6.2.2 By Region - Global Febrile Neutropenia Revenue, 2022-2027
  6.2.3 By Region - Global Febrile Neutropenia Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Febrile Neutropenia Revenue, 2016-2027
  6.3.2 US Febrile Neutropenia Market Size, 2016-2027
  6.3.3 Canada Febrile Neutropenia Market Size, 2016-2027
  6.3.4 Mexico Febrile Neutropenia Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Febrile Neutropenia Revenue, 2016-2027
  6.4.2 Germany Febrile Neutropenia Market Size, 2016-2027
  6.4.3 France Febrile Neutropenia Market Size, 2016-2027
  6.4.4 U.K. Febrile Neutropenia Market Size, 2016-2027
  6.4.5 Italy Febrile Neutropenia Market Size, 2016-2027
  6.4.6 Russia Febrile Neutropenia Market Size, 2016-2027
  6.4.7 Nordic Countries Febrile Neutropenia Market Size, 2016-2027
  6.4.8 Benelux Febrile Neutropenia Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Febrile Neutropenia Revenue, 2016-2027
  6.5.2 China Febrile Neutropenia Market Size, 2016-2027
  6.5.3 Japan Febrile Neutropenia Market Size, 2016-2027
  6.5.4 South Korea Febrile Neutropenia Market Size, 2016-2027
  6.5.5 Southeast Asia Febrile Neutropenia Market Size, 2016-2027
  6.5.6 India Febrile Neutropenia Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Febrile Neutropenia Revenue, 2016-2027
  6.6.2 Brazil Febrile Neutropenia Market Size, 2016-2027
  6.6.3 Argentina Febrile Neutropenia Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Febrile Neutropenia Revenue, 2016-2027
  6.7.2 Turkey Febrile Neutropenia Market Size, 2016-2027
  6.7.3 Israel Febrile Neutropenia Market Size, 2016-2027
  6.7.4 Saudi Arabia Febrile Neutropenia Market Size, 2016-2027
  6.7.5 UAE Febrile Neutropenia Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Xenetic Biosciences, Inc. (XBIO)
  7.1.1 Xenetic Biosciences, Inc. (XBIO) Corporate Summary
  7.1.2 Xenetic Biosciences, Inc. (XBIO) Business Overview
  7.1.3 Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Major Product Offerings
  7.1.4 Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Revenue in Global (2016-2021)
  7.1.5 Xenetic Biosciences, Inc. (XBIO) Key News
7.2 Richter Gedeon Nyrt.
  7.2.1 Richter Gedeon Nyrt. Corporate Summary
  7.2.2 Richter Gedeon Nyrt. Business Overview
  7.2.3 Richter Gedeon Nyrt. Febrile Neutropenia Major Product Offerings
  7.2.4 Richter Gedeon Nyrt. Febrile Neutropenia Revenue in Global (2016-2021)
  7.2.5 Richter Gedeon Nyrt. Key News
7.3 Amgen Inc.
  7.3.1 Amgen Inc. Corporate Summary
  7.3.2 Amgen Inc. Business Overview
  7.3.3 Amgen Inc. Febrile Neutropenia Major Product Offerings
  7.3.4 Amgen Inc. Febrile Neutropenia Revenue in Global (2016-2021)
  7.3.5 Amgen Inc. Key News
7.4 Hospira, Inc.
  7.4.1 Hospira, Inc. Corporate Summary
  7.4.2 Hospira, Inc. Business Overview
  7.4.3 Hospira, Inc. Febrile Neutropenia Major Product Offerings
  7.4.4 Hospira, Inc. Febrile Neutropenia Revenue in Global (2016-2021)
  7.4.5 Hospira, Inc. Key News
7.5 Eli Lilly and Company
  7.5.1 Eli Lilly and Company Corporate Summary
  7.5.2 Eli Lilly and Company Business Overview
  7.5.3 Eli Lilly and Company Febrile Neutropenia Major Product Offerings
  7.5.4 Eli Lilly and Company Febrile Neutropenia Revenue in Global (2016-2021)
  7.5.5 Eli Lilly and Company Key News
7.6 USV Private Limited
  7.6.1 USV Private Limited Corporate Summary
  7.6.2 USV Private Limited Business Overview
  7.6.3 USV Private Limited Febrile Neutropenia Major Product Offerings
  7.6.4 USV Private Limited Febrile Neutropenia Revenue in Global (2016-2021)
  7.6.5 USV Private Limited Key News
7.7 Aequus BioPharma, Inc.
  7.7.1 Aequus BioPharma, Inc. Corporate Summary
  7.7.2 Aequus BioPharma, Inc. Business Overview
  7.7.3 Aequus BioPharma, Inc. Febrile Neutropenia Major Product Offerings
  7.4.4 Aequus BioPharma, Inc. Febrile Neutropenia Revenue in Global (2016-2021)
  7.7.5 Aequus BioPharma, Inc. Key News
7.8 Taiho Pharmaceutical Co., Ltd.
  7.8.1 Taiho Pharmaceutical Co., Ltd. Corporate Summary
  7.8.2 Taiho Pharmaceutical Co., Ltd. Business Overview
  7.8.3 Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Major Product Offerings
  7.8.4 Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Revenue in Global (2016-2021)
  7.8.5 Taiho Pharmaceutical Co., Ltd. Key News
7.9 BeyondSpring Inc.
  7.9.1 BeyondSpring Inc. Corporate Summary
  7.9.2 BeyondSpring Inc. Business Overview
  7.9.3 BeyondSpring Inc. Febrile Neutropenia Major Product Offerings
  7.9.4 BeyondSpring Inc. Febrile Neutropenia Revenue in Global (2016-2021)
  7.9.5 BeyondSpring Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Febrile Neutropenia Market Opportunities & Trends in Global Market
Table 2. Febrile Neutropenia Market Drivers in Global Market
Table 3. Febrile Neutropenia Market Restraints in Global Market
Table 4. Key Players of Febrile Neutropenia in Global Market
Table 5. Top Febrile Neutropenia Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Febrile Neutropenia Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Febrile Neutropenia Revenue Share by Companies, 2016-2021
Table 8. Global Companies Febrile Neutropenia Product Type
Table 9. List of Global Tier 1 Febrile Neutropenia Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Febrile Neutropenia Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Febrile Neutropenia Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Febrile Neutropenia Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Febrile Neutropenia Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Febrile Neutropenia Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Febrile Neutropenia Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Febrile Neutropenia Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Febrile Neutropenia Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Febrile Neutropenia Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Febrile Neutropenia Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Febrile Neutropenia Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Febrile Neutropenia Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Febrile Neutropenia Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Febrile Neutropenia Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Febrile Neutropenia Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Febrile Neutropenia Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Febrile Neutropenia Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Febrile Neutropenia Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Febrile Neutropenia Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Febrile Neutropenia Revenue, (US$, Mn), 2022-2027
Table 30. Xenetic Biosciences, Inc. (XBIO) Corporate Summary
Table 31. Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Product Offerings
Table 32. Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Revenue (US$, Mn), (2016-2021)
Table 33. Richter Gedeon Nyrt. Corporate Summary
Table 34. Richter Gedeon Nyrt. Febrile Neutropenia Product Offerings
Table 35. Richter Gedeon Nyrt. Febrile Neutropenia Revenue (US$, Mn), (2016-2021)
Table 36. Amgen Inc. Corporate Summary
Table 37. Amgen Inc. Febrile Neutropenia Product Offerings
Table 38. Amgen Inc. Febrile Neutropenia Revenue (US$, Mn), (2016-2021)
Table 39. Hospira, Inc. Corporate Summary
Table 40. Hospira, Inc. Febrile Neutropenia Product Offerings
Table 41. Hospira, Inc. Febrile Neutropenia Revenue (US$, Mn), (2016-2021)
Table 42. Eli Lilly and Company Corporate Summary
Table 43. Eli Lilly and Company Febrile Neutropenia Product Offerings
Table 44. Eli Lilly and Company Febrile Neutropenia Revenue (US$, Mn), (2016-2021)
Table 45. USV Private Limited Corporate Summary
Table 46. USV Private Limited Febrile Neutropenia Product Offerings
Table 47. USV Private Limited Febrile Neutropenia Revenue (US$, Mn), (2016-2021)
Table 48. Aequus BioPharma, Inc. Corporate Summary
Table 49. Aequus BioPharma, Inc. Febrile Neutropenia Product Offerings
Table 50. Aequus BioPharma, Inc. Febrile Neutropenia Revenue (US$, Mn), (2016-2021)
Table 51. Taiho Pharmaceutical Co., Ltd. Corporate Summary
Table 52. Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Product Offerings
Table 53. Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Revenue (US$, Mn), (2016-2021)
Table 54. BeyondSpring Inc. Corporate Summary
Table 55. BeyondSpring Inc. Febrile Neutropenia Product Offerings
Table 56. BeyondSpring Inc. Febrile Neutropenia Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Febrile Neutropenia Segment by Type
Figure 2. Febrile Neutropenia Segment by Application
Figure 3. Global Febrile Neutropenia Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Febrile Neutropenia Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Febrile Neutropenia Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Febrile Neutropenia Revenue in 2020
Figure 8. By Type - Global Febrile Neutropenia Revenue Market Share, 2016-2027
Figure 9. By Application - Global Febrile Neutropenia Revenue Market Share, 2016-2027
Figure 10. By Region - Global Febrile Neutropenia Revenue Market Share, 2016-2027
Figure 11. By Country - North America Febrile Neutropenia Revenue Market Share, 2016-2027
Figure 12. US Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Febrile Neutropenia Revenue Market Share, 2016-2027
Figure 16. Germany Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 17. France Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Febrile Neutropenia Revenue Market Share, 2016-2027
Figure 24. China Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 28. India Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Febrile Neutropenia Revenue Market Share, 2016-2027
Figure 30. Brazil Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Febrile Neutropenia Revenue Market Share, 2016-2027
Figure 33. Turkey Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Febrile Neutropenia Revenue, (US$, Mn), 2016-2027
Figure 37. Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Richter Gedeon Nyrt. Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Amgen Inc. Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Hospira, Inc. Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Eli Lilly and Company Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. USV Private Limited Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Aequus BioPharma, Inc. Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications